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Introduction 76
A landmark Australian study, the Quality of Australian Health Care Study (QAHCS), 77 reviewed the quality of delivered health care and concluded that 16.6% of admissions were 78 associated with adverse events (AEs) each year [1] . More than 50% of the AEs reported were 79 associated with surgery and up to 48% of these AEs were considered preventable. The 80 estimated costs associated with these AEs are exorbitant, at AU$ 1-2 billion dollars [2] . 81
Recent studies based on 2003-2004 data have shown that the cost of AEs in Australia could 82 exceed AU$ 2 billion per year [3] . 83
84
In recent decades there has been a worldwide development towards reporting and analyzing 85 the quality of delivered healthcare in specialized centers and, more specifically, in the field of 86 surgery. This is arguably a direct consequence of 'variations' in outcomes noticed among 87 different institutions for similar procedures. The shift in clinical attitudes towards greater 88 transparency in performance regarding the quality of care to improve outcomes has led to a 89 number of studies focusing on post-operative morbidity and mortality and the formation of 90 adequate and validated models of risk assessment [4] . Such studies have had a positive 91 influence on the quality of surgical practice and contributed to reduced AE rates [5] . 92
93
The occurrences of AEs during or following a surgical procedure are not uncommon, 94 especially in high-risk specialties such as surgical oncology. Surgeons in these sub-specialties 95 utilize state-of-the-art procedures, innovative minimally-invasive techniques, combined with 96 chemotherapy and or radiotherapy to improve patient outcomes. However, these procedures 97 and management approaches are associated with serious risks of AEs, along with patient 98 related and environmental factors, and are estimated to vary from 34% in head and neck 99 cancers to as high as 69% in esophageal cancers [6] . The published incidence of AEs among patients with gynaecological cancer varies from 26% to 54% [6, 7] . As there is potential scope 101 for reducing AEs among these women, it is important to have a sound understanding of the 102 current clinical outcomes as well as the economic costs so that future intervention studies can 103 be adequately planned for and assessed for their effectiveness and cost-effectiveness. 104 Therefore, the aim of our study was to quantify the nature and extent of AEs in the 105 subspecialty of gynaecological oncology and estimate their associated hospital costs. 106
107
Methods 108
All patients who underwent a laparoscopic procedure or laparotomy for suspected or proven 109 gynaecological malignancies were enrolled from a major tertiary referral hospital in the state 110 of Queensland, Australia. All the AEs were recorded prospectively between 1 st January 2007 111 and 20 th August 2008 by a dedicated patient safety officer. We reviewed all the medical 112 records for potential risk factors for AEs. The methods have been previously reported [7] but 113 briefly, all patients who underwent surgery between 1 st January 2007 and 30 th June 2008 were 114 included. We reviewed electronic and paper-based medical records and extracted information 115 related to: (1) patient-related risk factors (e.g., BMI, age); (2) clinical characteristics from pre-116 operative lab results (e.g., serum albumin and liver function tests); (3) surgical procedures 117 (type and complexity of procedure, approach, duration of surgery, conversions, surgeon's 118 experience (trainee/consultant)); (4) type of AEs classified as intra-operative or post-119 operative; and (5) other outcomes such as length of hospital stay and death within 30 days) 120
[7]. Intra-operative AEs included injuries to the bladder, bowel, ureter, blood vessels, nerves 121 and the need for intra-operative blood transfusions and post-operative AEs included wound 122 infection, wound dehiscence, wound hematoma, secondary hematoma, pneumonia, pulmonary 123 embolism, urinary tract infections, renal complication, stroke/cerebrovascular accidents, 124 pelvic abscess, subphrenic abscess, other abscesses, septicemia, deep venous thrombosis, gastric ileus, urinary fistula, gastro-intestinal fistula, cardiac complications and other post-126 operative events. These post-operative events were further classified into minor and major 127 events based on the nature of the treatment used to manage these events. 128
To permit comparison of AE rates over time and across studies, post-operative AEs were 129 classified using a standardized grading system Data linkage was achieved using a hospital identification number. The cost information was 140 retrieved from the hospital's detailed costing system (Transition Systems Inc) which tracks all 141 the resources used in caring for the patient. The total cost for the aggregated hospital 142 resources used by each patient was provided to the research team and no further breakdown of 143 the types of hospital resources were provided. As specific resource quantities were not 144 separated from costs, here we used the aggregated cost figure and assumed that excess costs 145 for the group of patients with AEs were fully attributed to the AEs. 146 147
Statistical analyses 148
Descriptive statistics were used to show baseline characteristics of patients. Multivariate 149 modeling was used to quantify costs attributed to AEs adjusted for various clinical factors.
As health cost data is commonly skewed to reflect that some patients accrue very high costs, 151 total patient costs for patients were log-transformed before using multivariate ordinary least 152 squared regression. Re-transforming costs back to the raw cost scale were achieved with 153
Duan's smearing factors [9] . We tested the model assumptions by examining the normality 154 and heteroskedasticity of residuals while goodness-of-fit and model specification was Results 174 175
Overall the 369 women in the study ranged in age from 13 to 91 years with a mean (SD) age 176 at the time of surgery of 56.3 (14.4) years with 63 patients (17.1%) aged ≥ 70 years (Table 1) . 177
The mean (SD) BMI was 30.3 (8.2) kg/m² with 44.7% of patients classified as obese (BMI ≥ 178 30). 179
180
The most common surgical procedures were hysterectomy and salpingo-oophorectomy 181 followed by pelvic, para-aortic and groin lymph node dissection (Table 1) Hospital length of stay was 6.4 days (SD 11.1) on average for all women and ranged from 0.4 204 to 196 (Table 3) . Women with major post-operative AEs had the longest average stay of 32.8 205 days (95% CI: 4.2 to 61.5) compared with those with minor AEs (8.0 days, 95% CI: 7.2 to 206 8.8), intra-operative AEs (18.1 days, 95% CI: 4.2 to 32.0) and no AEs (4.8 days, 95% CI: 4.5 207 to 5.1). 208
209
In the log-transformed regression model, the residuals were heteroskedastic with respect to 210 presence of AEs and therefore costs were re-transformed to the raw cost scale with separate 211
Duan's smearing estimators for patients with or without AEs ( (Table 4) . 228
Adjusted LOS was also higher overall for laparotomy 7.9 days (95% CI 7.2, 8.5 days) than 229 laparoscopy 4.7 days (95% CI 1.2, 8.2 days). Adjusted mean costs were AU $4,000 to $5,000 230 higher for patients receiving laparotomy compared with laparoscopy when there were no 231 complications or no major postoperative complications. When laparoscopy was used to treat 232 patients with confirmed malignancy, adjusted costs were substantially lower, AU$ 12,300 233 (95%CI: $11,525, $13,075) versus laparotomy AU$19,168 (95%CI: 17,159, $21,176). For 234 patients receiving either laparoscopic or laparotomy surgery, adjusted costs were higher for 235 patients with ovarian cancer, compared with patients with other gynecological cancers but 236 tumor site was not a strong predictor of patient costs (Table 4) A quarter of all patients requiring surgery for proven or suspected gynaecological cancer 254 develop at least one adverse event (AE) and incur higher hospitalization costs and longer 255 hospital stays. This study highlights that even when relevant risk factors are controlled for, the 256 costs remain significantly high in comparison with those who did not experience any AEs. 257
Our findings also confirm that patients receiving laparoscopic surgery in this sub-specialty 258 have shorter hospital stays and incur overall lower costs than those receiving more traditional 259 open surgical techniques. 260
261
Most of the information currently available on the incidence of surgical AEs has been 262 obtained from surgery for benign gynecological conditions. The incidence rates of bladder 263 and ureteral injury are 1.6% and 0.5%, respectively, in this series which compares well with 264 3.6% and 1.7% in the current literature [12, 13] . The incidence of post-operative wound-265 related issues varies from 3% to 10% in the literature [14] whereas in our study it was 9%. 266
Post-operative cardiac complications are also within expectations in our study (1.9%) 267 compared to the published literature (3%) [15] . In general, the rates of AEs in our series are 268 comparable to the rates published for patients treated for benign gynecological conditions. 269
Sixty-five percent of patients in our series had a malignant condition and our study shows that 270
AEs are more common among patients with a malignant condition (30%) compared to 271 patients who underwent surgery for prophylaxis or a benign condition (p=0.009). However, 272 our study also shows that AE rates associated with procedures performed by trainees were not 273 significantly different to those of certified gynecologic oncologists (p=0.522). 274
275
A major strength of our study is that the AEs were collected prospectively on a consecutive 276 real-world sample of gynecological patients with minimal missing data. This avoids the 277 criticism of under-reporting associated with retrospective studies on selected patients. Furthermore, surgeons and other staff were blinded to study participation and therefore were 279 unlikely to bias patient selection and subsequent management or change their routine use of 280 hospital resources. However, our patients were recruited from a single, high-volume tertiary 281 referral center and therefore omit the potential variation in outcomes that may exist among 282 patients across multiple health care facilities, and treated by a range of physicians. Patients 283 treated in private health care facilities may have different AE rates and associated costs than 284 those treated in public hospitals. However, we have addressed this uncertainty using 285 probabilistic sensitivity analysis and found results to be robustwere stable to plausible 286 variations in incidence of AEs. The regression modeling that we used may underestimate the 287 actual costs associated with AEs, as our analyses were limited to events identified during the 288 episode of care and up to a maximum of 30 days. Also, indirect costs such as patient and 289 family travel and out-of-pocket expenses, time spent caring for the patient, and community 290 health resources utilized, have not been taken into account. Therefore the true burden of AEs 291 on patients and society will be higher. 292
293
We performed a sensitivity analysis with the incidence rates of intra-operative and post-294 operative AEs varying by ± 10% and ± 20% (Table 5 ). Evidence suggests that certain 295 interventions may reduce the incidence of surgical complications [16] . Assuming a 296 conservative 20% reduction across all complications, the savings Australia-wide will be at 297 least AU$3.8 million from intra-op AEs, AU$3.6 million from minor AEs and another 298 AU$2.9 million from major AEs. Our prior work on surgical risk prediction can help identify 299 those who are at a higher risk for AEs and appropriate precautions can be taken to minimize 300 such events [7] . This risk scoring system has attracted attention among specialists in the field 301 of gynecologic oncology [17] [18] [19] . 302 303 Innovative medical technologies, improvements in overall survival, greater emphasis on the 304 quality of delivered care and increasing disease burden all contribute to escalating health care 305 costs and straining health care budgets in most developed countries. Even though we used 306 conservative estimates of 10% and 20% reduction in AE rates, some researchers estimate that 307 40% of AEs are preventable [20] . If reductions in AE of this magnitude can be achieved, it 308 will significantly reduce patient suffering, enable a speedier recovery, improve their hospital 309 experience and ultimately, reduce excess hospital costs. 310
311
In conclusion, AEs in gynaecological oncology may occur in 26% of patients with 4% 312 considered to be of major severity. Hospital costs attributed to AEs are in the order of 313 AU$12,780 per patient in our sample, on average, but are significantly higher for those with 314 major complications and receiving laparotomies after accounting for baseline risk factors. 315
There is considerable scope for hospital cost-savings if evidence-based mechanisms to reduce 316 the incidence of adverse events are adopted. 317 318 Conflict of interest statement: 320 321
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